参考文献/References:
［1］Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome［J］. Nat Rev Dis Primers, 2016, 2: 16057.
［2］LI Rong, ZHANG Qiufang, YANG Dongzi, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study ［J］.Human Reproduction,2013,28(9):2562-2569.
［3］中华医学会妇产科学分会内分泌学组及指南专家组．多囊卵巢综合征中国诊疗指南 ［J］．中华妇产科杂志，2018，53（1）：2-6．
［4］Teede H J, Misso M L, Costello M F, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome ［J］. Human Reproduction, 2018, 33 (9): 1602-1618.
［5］Legro R S, Dodson W C, Kris-etherton P M, et al. Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome ［J］. Journal of Clinical Endocrinology & Metabolism,2015,100(11):4048-4058.
［6］Azadi-yazdI M,Karimi-zarchi M,Salehi-abargouei A,et al.Effects of dietary approach to stop hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial ［J］. Journal of Human Nutrition and Dietetics, 2017, 30 (3): 275-283.
［7］Nybacka A, Carlstrom K, Stahle A, et al. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome ［J］. Fertility and Sterility, 2011, 96 (6): 1508-1513.
［8］Smithson D S, Vause T R, Cheung A P. 362-Ovulation induction in polycystic ovary syndrome ［J］.Journal of Obstetrics and Gynaecology Canada，2018, 40 (7): 978-987.
［9］Boomsma C M,Eijkemans M,Hughes E G,et al.A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome ［J］. Human Reproduction, 2006, 12(6):673-683.
［10］Sterling L, Liu J, Okun N, et al. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization ［J］. Fertility and Sterility, 2016, 105 (3): 791-797.e 2.
［11］Balen A H, Morley L C, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance ［J］. Human Reproduction Update, 2016, 22 (6): 687-708.
［12］Legro R S, Brzyski R G, Diamond M P, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome ［J］.The New England Journal of Medicine,2014,371(2):119-
129.
［13］Amer S A, Smith J, Mahran A, et al. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome ［J］. Human Reproduction, 2017, 32 (8): 1631-1638.
［14］Franik S, Eltrop S M, Kremer J A, et al. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome ［J］. Cochrane Database of Systematic Reviews, 2018 (5): Cd010287.
［15］Acog Practice Bulletin No. 194 Summary: Polycystic ovary syndrome ［J］. Obstetrics and Gynecology, 2018,131(6):e 175-e 171.
［16］Mejia R B, Summers K M, Kresowik J D, et al. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome ［J］. Fertility and Sterility, 2019, 111 (3): 571-578.e 1.
［17］Wallace K L, Johnson V, Sopelak V, et al. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome ［J］. Fertility and Sterility, 2011, 96 (4): 1051-1056.
［18］Zain M M, Jamaluddin R, Ibrahim A, et al. Comparison of clomiphene citrate, metformin, or the combination of both for firstline ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial ［J］. Fertility and Sterility, 2009, 91 (2): 514-521.
［19］Legro R S, Barnhart H X, Schlaff W D, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome ［J］. New England Journal of Medicine, 2007, 356 (6): 551-566.
［20］Misso M L, Teede H J, Hart R, et al. Status of clomiphene citrate and metformin for infertility in PCOS ［J］. Trends in Endocrinology and Metabolism, 2012, 23 (10): 533-543.
［21］Practice Committee of the American Society for Reproductive Medicine. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline ［J］. Fertility and Sterility, 2017, 108 (3):426-441.
［22］Christin-maitre S, Hugues J N, Recombinant FSH Study Grp. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome ［J］. Human Reproduction, 2003, 18 (8): 1626-1631.
［23］Weiss N S, Kostova E, Nahuis M, et al. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome ［J］. Cochrane Database of Systematic Reviews, 2019 (1): Cd010290.
［24］Hendriks M L, Ket J C, Hompes P G, et al. Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome ［J］. Human Reproduction Update, 2007, 13 (3): 249-264.
［25］Bayram N, Van Wely M, Kaaijk E M, et al. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial ［J］. British Medical Journal, 2004, 328 (7433): 192-195.
［26］Nahuis M J, Kose N, Bayram N, et al. Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins ［J］. Human Reproduction,2011, 26 (7): 1899-1904.
［27］Farquhar C, Brown J, Marioribanksj. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome ［J］.Cochrane Database of Systematic Reviews, 2012 (2): Cd001122.
［28］Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews ［J］. Cochrane Database of Systematic Reviews, 2017 (1): Cd012103.
［29］Lambalk C B, Banga F R, Huirne J A, et al. GnRH antagonist versus long agonist protocols in IVF. A systematic review and meta-analysis accounting for patient type ［J］. Human Reproduction, 2015, 30 (1): 428.
［30］Zhang B, Wei D, Legro R S, et al. Obstetric complications after frozen versus fresh embryo transfer in women with polycystic ovary syndrome: results from a randomized trial ［J］. Fertility and Sterility, 2018, 109 (2): 324-329.
［31］Tso L O, Costello M F, Albuquerque L E, et al. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome ［J］. Cochrane Database of Systematic Reviews, 2014 (11): Cd006105.
［32］Yu E J, Yoon T K, Lee W S, et al. Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oocytes ［J］. Fertility and Sterility, 2019, 112 (4): 691-699.
［33］Mostinckx L, Segers I, Belva F, et al. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation ［J］. Human Reproduction, 2019, 34 (8): 1595-1607.
［34］Siristatidis C S, Maheshwari A, Vaidakis D, et al. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction ［J］. Cochrane Database of Systematic Reviews, 2018 (11): Cd006606.
［35］Hatirnaz S, Hatirnaz E, Dahan M H, et al. Is elective single-embryo transfer a viable treatment policy in in vitro maturation cycles? ［J］. Fertility and Sterility, 2016, 106 (7): 1691-1695.
相似文献/References:
[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.